drugset / Trial / NCT00847405
Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
The objective of this study is to compare the rate and extent of absorption of sumatriptan from a test formulation of Sumatriptan Succinate 100 mg Tablets versus the reference Imitrex® 100 mg Tablets under fasting conditions.
Timeline
- Start
- 2003-03
- Primary completion
- 2003-03
- Completion
- 2003-03
Outcome
Met primary endpoint
registry Ratio of the T/R geometric mean x 100 103.64 (90% CI 95.93 to 111.97) NCT00847405 ↗
registry Ratio of the T/R geometric mean x 100 102.81 (90% CI 97.95 to 107.91) NCT00847405 ↗
registry Ratio of the T/R geometric mean x 100 103.25 (90% CI 98.35 to 108.41) NCT00847405 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sumatriptan | Unknown | 100 mg | — |
Indications
No indication recorded.